These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4319621)

  • 21. Resistance to polymyxins: Mechanisms, frequency and treatment options.
    Falagas ME; Rafailidis PI; Matthaiou DK
    Drug Resist Updat; 2010; 13(4-5):132-8. PubMed ID: 20843473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
    J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro sensitivity of 368 urinary organisms to trimethoprim-sulphamethoxazole and other antibacterials.
    Hunter IJ
    Med J Aust; 1970 Aug; 2(7):317-21. PubMed ID: 4319442
    [No Abstract]   [Full Text] [Related]  

  • 24. Synergism between polymyxins, polysorbate and antimetabolites of folic acid synthesis, and a paper disc technique for routine testing for synergism.
    Quesnel LB; Handley PS
    Microbios; 1974 May; 10(40):199-210. PubMed ID: 4369254
    [No Abstract]   [Full Text] [Related]  

  • 25. [Sensitivity to antibiotics of Escherichia coli strains isolated from children admitted to the "Sf. Ioan" clinical emergency hospital for children in Galaţi during 2005-2006].
    Florea C
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(1-2):37-44. PubMed ID: 18441957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colistin and polymyxin B in critical care.
    Michalopoulos A; Falagas ME
    Crit Care Clin; 2008 Apr; 24(2):377-91, x. PubMed ID: 18361952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymyxins and their novel derivatives.
    Vaara M
    Curr Opin Microbiol; 2010 Oct; 13(5):574-81. PubMed ID: 20869908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of polymyxins in combination with β-lactams against clinical strains of Pseudomonas aeruginosa.
    Mitsugui CS; Tognim MC; Cardoso CL; Carrara-Marroni FE; Botelho Garcia L
    Int J Antimicrob Agents; 2011 Nov; 38(5):447-50. PubMed ID: 21872449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.
    Falagas ME; Kasiakou SK
    Clin Infect Dis; 2005 May; 40(9):1333-41. PubMed ID: 15825037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic and toxicologic studies with the polymyxins. II. Comparative pharmnacologic studies of the sulfate and methanesulfonate salts of polymyxin B and colistin in dogs.
    al-Khayyat AA; Aronson AL
    Chemotherapy; 1973; 19(2):82-97. PubMed ID: 4357724
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment strategy for a multidrug-resistant Klebsiella UTI.
    Fleming E; Heil EL; Hynicka LM
    Ann Pharmacother; 2014 Jan; 48(1):123-7. PubMed ID: 24259631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility and resistance of various strains of Mycoplasma hyorhinis to antisera, polymyxins and low pH values.
    Dinter Z; Taylor-Robinson D
    J Gen Microbiol; 1969 Aug; 57(2):263-72. PubMed ID: 4310937
    [No Abstract]   [Full Text] [Related]  

  • 33. [Epidemiological and microbiological evaluation of nosocomial infections caused by Candida species].
    Erdem F; Tuncer Ertem G; Oral B; Karakoç E; Demiröz AP; Tülek N
    Mikrobiyol Bul; 2012 Oct; 46(4):637-48. PubMed ID: 23188577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.
    Wisplinghoff H; Ebbers J; Geurtz L; Stefanik D; Major Y; Edmond MB; Wenzel RP; Seifert H
    Int J Antimicrob Agents; 2014 Jan; 43(1):78-81. PubMed ID: 24182454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymyxins: wisdom does not always come with age.
    Kassamali Z; Rotschafer JC; Jones RN; Prince RA; Danziger LH
    Clin Infect Dis; 2013 Sep; 57(6):877-83. PubMed ID: 23728146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combinations of antimicrobial agents: II. The in vitro sensitivity of 52 strains of proteus species to sulphafurazole, polymyxins and combinations of sulphafurazole and polymyxins.
    Kuipers JS
    Arch Chir Neerl; 1976; 28(1):33-41. PubMed ID: 180905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of methacolimycin for urinary tract infections].
    Watanabe M; Kawamura S; Ishizaki M
    Hinyokika Kiyo; 1967 Feb; 13(2):175-81. PubMed ID: 5624107
    [No Abstract]   [Full Text] [Related]  

  • 38. [In vitro antifungal activity of nitroxoline. Preliminary clinical results].
    Cancet B; Amgar A
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):879-81. PubMed ID: 3309833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09).
    Gales AC; Jones RN; Sader HS
    J Antimicrob Chemother; 2011 Sep; 66(9):2070-4. PubMed ID: 21715434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Local application of Polymyxin B for gram-negative infections in urology].
    Wada I
    Hinyokika Kiyo; 1968 Sep; 14(9):687-90. PubMed ID: 4303440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.